1. Market Research
  2. > Internet Business
  3. > E-Healthcare Market Trends

The Impact of Mobile Health on Patient-Centric Disease Management

  • August 2013
  • 105 pages
  • Firstword Pharma
Report ID: 1601322


Table of Contents

Banks use them. So does the travel industry. And tastemakers are harnessing their power every day. Now, it’s pharma’s turn to explore mobile and digital apps.

In an age where patients are well-informed and thus have a stronger-than-ever sense of ownership over their disease, there is mounting evidence that mobile health apps are affecting outcomes. Well-designed and intuitive, health apps can helping clinicians and healthcare providers better manage treatments, even after they leave the consulting rooms. As a result, patient adherence can improve.

So what’s in it for the pharmaceutical industry? Better health outcomes mean improved market access and greater brand loyalty. What’s more, as pharma taps into the mobile health industry—set to grow to US$30 billion in three years, according to some estimates—real world data looped back from platforms will have far-reaching implications for drug development and clinical trials.

Through The Impact of Mobile Health on Patient-Centric Disease Management, FirstWord explores the emerging and exciting world of mobile and digital health apps. Based on interviews from nine industry experts, reviews of clinical and commercial opportunities and case studies, the report offers insight into app development, integration, and how the industry can capture the market now and in the future.

Report Highlights of The Impact of Mobile Health on Patient-Centric Disease Management include:

Expert opinion from those working at the forefront of the emerging mHealth industry, including experts from GlaxoSmithKline, Boehringer Ingelheim, UCB and Janssen Healthcare
Overview of clinical and commercial opportunities and realities. with implications for patients, clinicians and pharma
Case studies of new, established and successful platforms, covering diabetes, schizophrenia, adherence, cognitive behavioural therapy and epilepsy
Insight into the use of data for clinical patient management

Key Benefits

While mobile and digital health apps are relatively new to pharma, there are clear signs they present excellent opportunities for the industry. In The Impact of Mobile Health on Patient-Centric Disease Management, FirstWord explores this exciting new area. Amongst the benefits, this report will help you to:

Understand the parameters of the booming mobile app business, as it applies to pharma
Learn the critical path for development of apps, platforms, gamification and optimising patient engagement
Understand how real world data gathered can make a difference in drug development and meeting demands for data from regulators and reimbursement agencies
Develop key knowledge about how mobile, digital and healthcare industries will grow together

Key Questions Answered

The Impact of Mobile Health on Patient-Centric Disease Management answers key questions:

How can pharma harness the mobile and digital app industry?
What returns can pharma expect by developing mobile and digital apps?
What are the most successful apps to date and what garnered their success?
What are the key benefits of mobile technology for pharma, patients and physicians?
What is the future of digital and mobile health apps?

Selected quotes from the report

“Use of these platforms means that patients are taking responsibility for themselves; that’s the magic bullet in a way, and that gets a win for everyone.” David Proudlock, GSK

“Effectively, the healthcare professional or other stakeholder starts to have a better view of the patient’s clinical management outside of the consulting room, helping to prevent events, and enabling the provision of care for patients remotely. It’s a very different experience for patients, but it’s certainly something that patients tell us they want to see happen.” Michael Morgan-Curran from the GSMA

“If we say to a payer, we have a drug but we also have a proven and remote monitoring device through a partner company so when a patient gets the drug they also get the mobile health device or app and we have proven studies, then we might be in a preferential position compared to a competitor molecule. We would have a better position from a market access perspective.” Wolfgang Renz, Boehringer Ingelheim

Expert Views

Larry Brooks, Director, Business Model & Healthcare Innovation at Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)
Tony Free, developer of iThinkSmarter smartphone app and cognitive behavioural therapist, Yorkshire, UK
Graham Howieson, CEO at GP Solutions (UK) Ltd, in Manchester, UK
Navin Joshi, Senior Director, Customer Solutions in Access to Medicines at GlaxoSmithKline
Marco Mohwinckel, partner at Janssen Healthcare Innovation, Europe, Middle East and Africa
Michael Morgan-Curran, Global Director of mHealth & Diabetes Programme Director at the GSMA (GSM Association)
Roger Palframan, Head of Innovation Super Networks at UCB
David Proudlock, Director, Innovation and Disruptive Technologies - UK Pharma at GlaxoSmithKline
Wolfgang Renz, Corporate Vice President, Business Model & Healthcare Innovation, Boehringer Ingelheim based in the U.S

Content Highlights
Mobile and digital health apps are being developed with great success in pockets of the industry. In this report, you will discover:

The importance of digital platforms and mobile apps in providing integrated health solutions
The hidden value of mobile apps in collating, distributing and analysing real world data
The current state-of-play for regulations, leading up to the FDA’s pending guidance on mobile apps

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Home Health Care And Residential Nursing Care Services Market Global Report 2017

  • $ 6000
  • Industry report
  • July 2017
  • by TBRC Business Research

Home health care refers to wide range of health care services that are provided to individuals at their residence for any illness or injury. Residential nursing care refers to provision of long- or short-term ...

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (Practice Management, Patient Management, Referral Management, Health Analytics), Practice Size (Large, Small-to-medium, Solo), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • May 2017
  • by MarketsandMarkets

The global ambulatory EHR market is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The ambulatory EHR market is undergoing ...

Pharmacy Automation Market by Product, Packaging & Labeling System, Tabletop Counter, Storage System), End User - Global Forecast to 2022

  • $ 5650
  • Industry report
  • April 2017
  • by MarketsandMarkets

The pharmacy automation market is expected to grow at a lucrative CAGR of 8.2% from 2017 to 2022, to reach USD 5.38 billion by 2022 from USD 3.63 billion in 2017. The growth in pharmacy automation market ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.